Anzeige
Mehr »
Donnerstag, 18.12.2025 - Börsentäglich über 12.000 News
Breaking News: Übernahme von Weltraum-Technologie ins Portfolio?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSG7 | ISIN: SE0015961982 | Ticker-Symbol: 0V0
Frankfurt
18.12.25 | 12:09
2,680 Euro
-2,26 % -0,062
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIMIAN GROUP AB Chart 1 Jahr
5-Tage-Chart
VIMIAN GROUP AB 5-Tage-Chart
RealtimeGeldBriefZeit
2,5422,71822:47

Aktuelle News zur VIMIAN GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.11.Barclays downgrades Vimian Group stock rating to Underweight on margin concerns1
24.11.Margensorgen: Barclays stuft Vimian-Aktie auf "Underweight" herab3
24.11.Vimian Group AB: Vimian Group AB (publ) appoints Alireza Tajbakhsh as CEO102Vimian Group AB (publ) ("Vimian") appoints Alireza Tajbakhsh as Chief Executive Officer, effective today. Alireza Tajbakhsh joined Vimian in 2021 and is currently Head of the Veterinary Services segment...
► Artikel lesen
22.10.Vimian-Aktie legt nach starken Q3-Zahlen um 7 % zu1
22.10.Vimian Group steigert Umsatz im dritten Quartal 2025 um 19 %1
22.10.Vimian Group Q3 2025 presentation: Revenue climbs 19% as MedTech returns to growth1
VIMIAN GROUP Aktie jetzt für 0€ handeln
22.10.Vimian Group AB: Vimian's Interim Report for the third quarter of 2025121Strong revenue and earnings growth in the third quarter Net revenue increased 19 per cent to EUR 104.3m (87.6) with organic growth of 9 per centAdjusted EBITA increased 17 per cent to EUR 25.5m (21.9)...
► Artikel lesen
01.09.Vimian gewinnt Rechtsstreit: Aktie legt nach Zuspruch von 40,2 Mio. US-Dollar zu2
01.09.Vimian Group AB shares rise after winning $40 million court decision2
30.08.Vimian Group AB: Superior Court of Delaware awards Vimian USD 40.2 million in indemnification dispute398The Superior Court of the State of Delaware in US has rendered a decision that the largest seller of Veterinary Orthopedic Implants, LLC ("VOI"), previously owning 55.6 percent of VOI, shall indemnify...
► Artikel lesen
23.07.Jefferies downgrades Vimian to "hold" on MedTech struggles, CEO exit1
18.07.Vimian Group reports 7% miss in Q2 adjusted EBITA3
18.07.Vimian Group: Bereinigtes EBITA für Q2 verfehlt Erwartungen um 7 %10
18.07.Vimian Group AB: Vimian's Interim Report for the second quarter of 2025202Solid revenue growth but weaker quarter in MedTech Net revenue increased by 15 per cent to EUR 104.3m (91.0) with organic growth of 5 per centAdjusted EBITA increased 3 per cent to EUR 25.4m (24.7)...
► Artikel lesen
17.07.Vimian Group AB: Vimian Group AB (publ) CEO Patrik Eriksson steps down219Today, Vimian Group AB (publ) ("Vimian") announces that Patrik Eriksson steps down from his position as CEO of Vimian with immediate effect. Carl-Johan Zetterberg Boudrie, CFO of Vimian, is appointed...
► Artikel lesen
29.04.Vimian Group AB: Vimian's Interim Report for the first quarter of 2025154Strong earnings growth and Main Market uplift Net revenue increased by 18 per cent to EUR 107.5m (91.3) with organic growth of 4 per centAdjusted EBITA increased 18 per cent to EUR 28.3m (24.1) corresponding...
► Artikel lesen
28.03.Nasdaq Stockholm Welcomes Vimian Group to the Main Market244Stockholm, 28 March 2025 - Nasdaq (Nasdaq: NDAQ) announces that trading in the shares of Vimian Group AB (ticker name: VIMIAN) will commence today on the Nasdaq Stockholm Main Market. Vimian Group...
► Artikel lesen
21.03.Listing Of Vimian Group AB (publ) On Nasdaq Stockholm250Nasdaq Stockholm AB has assessed that Vimian Group AB (publ), company registration number 559234-8923, fulfills Nasdaq Stockholm's listing requirements. Provided that Vimian Group AB (publ) applies...
► Artikel lesen
13.02.Vimian Group AB: Vimian's year-end report for 2024165Record sales quarter closes an eventful year Net revenue for the quarter increased by 27 per cent to EUR 104.9m (82.5) with organic growth of 15 per centAdjusted EBITA increased 9 per cent to EUR 24.6m...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1